Crossject – Trademark Portfolio
Entity Type: 99
Crossject holds 42 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 39 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 18 trademarks are registered and 3 are pending. Notable registered marks include HYZEPA, OPIZEP, OPZEPIO, RUZEPTA, and ZEPTISO. The owner is based in Paris.
12 quai Henri IV
Paris 75004 , FR
Showing of trademarks Trademarks
Trademark Classifications
Crossject's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Crossject have?
Crossject has 42 U.S. trademarks filed with the USPTO. Of these, 18 registered, 3 pending, 1 abandoned, 5 cancelled.
What trademark classes does Crossject file in?
Crossject files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Crossject's most well-known trademarks?
Crossject's registered trademark portfolio includes well-known marks such as HYZEPA, OPIZEP, OPZEPIO, RUZEPTA, and ZEPTISO. These are among 18 currently registered trademarks in the portfolio.
What is Crossject's trademark registration success rate?
Crossject has a 75% trademark registration rate, with 18 out of 24 resolved applications resulting in successful registration. Currently, 3 applications are pending review.